$2.24
-0.06[-2.61%]
At close: Apr 24
$2.24
0[0.00%]
After Hours: 5:04PM EDT
Finch Therapeutics Gr
(NASDAQ:FNCH)Finch Therapeutics Gr Stock (NASDAQ:FNCH), Analyst Ratings, Price Targets, Predictions
Finch Therapeutics Group Inc has a consensus price target of $12, established from looking at the 4 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co. on May 12, 2023, April 4, 2023, and August 9, 2022. With an average price target of $10.33 between HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied 361.31% upside for Finch Therapeutics Group Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Jefferies
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Finch Therapeutics Gr
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/12/2023 | FNCH | Buy Now | Finch Therapeutics Gr | $2.24 | 212.5% | HC Wainwright & Co. | Vernon Bernardino | $210 → $210 | Reiterates | Buy → Buy | Get Alert |
| 04/04/2023 | FNCH | Buy Now | Finch Therapeutics Gr | $2.24 | 212.5% | HC Wainwright & Co. | Vernon Bernardino | $510 → $210 | Reiterates | Buy → Buy | Get Alert |
| 08/09/2022 | FNCH | Buy Now | Finch Therapeutics Gr | $2.24 | 658.93% | HC Wainwright & Co. | Vernon Bernardino | → $510 | Initiates | → Buy | Get Alert |
| 04/04/2022 | FNCH | Buy Now | Finch Therapeutics Gr | $2.24 | 658.93% | Jefferies | Chris Howerton | $870 → $510 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Finch Therapeutics Gr (FNCH)?
The latest price target for Finch Therapeutics Gr (NASDAQ: FNCH) was reported by HC Wainwright & Co. on May 12, 2023. The analyst firm set a price target for $7.00 expecting FNCH to rise to within 12 months (a possible 212.50% upside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Finch Therapeutics Gr (FNCH)?
The latest analyst rating for Finch Therapeutics Gr (NASDAQ: FNCH) was provided by HC Wainwright & Co., and Finch Therapeutics Gr reiterated their buy rating.
When was the last upgrade for Finch Therapeutics Gr (FNCH)?
There is no last upgrade for Finch Therapeutics Gr.
When was the last downgrade for Finch Therapeutics Gr (FNCH)?
There is no last downgrade for Finch Therapeutics Gr.
When is the next analyst rating going to be posted or updated for Finch Therapeutics Gr (FNCH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Finch Therapeutics Gr, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Finch Therapeutics Gr was filed on May 12, 2023 so you should expect the next rating to be made available sometime around May 12, 2024.
Is the Analyst Rating Finch Therapeutics Gr (FNCH) correct?
While ratings are subjective and will change, the latest Finch Therapeutics Gr (FNCH) rating was a reiterated with a price target of $7.00 to $7.00. The current price Finch Therapeutics Gr (FNCH) is trading at is $2.24, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.